Risk of breast cancer in patients on long-acting insulin analogues in comparison with those on human insulin

被引：0

作者：

K. Kostev

机构：

[1] IMS Health,

[2] Centre of Excellence Patient Data,undefined

来源：

Diabetologia | 2012年 / 55卷

关键词：

Breast cancer; Detemir; Glargine; IMS disease analyzer; Insulin; NPH;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1554 / 1555

页数：1

共 9 条

[1]

Ruiter R(2012)Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study Diabetologia 55 51-62

[2]

Visser LE(2009)Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies Int J Clin Pharmacol Ther 47 617-626

[3]

van Herk-Sukel PP M(2005)Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 1130-1139

[4]

Becher H(undefined)undefined undefined undefined undefined-undefined

[5]

Kostev K(undefined)undefined undefined undefined undefined-undefined

[6]

Schröder-Bernhardi D(undefined)undefined undefined undefined undefined-undefined

[7]

Quan H(undefined)undefined undefined undefined undefined-undefined

[8]

Sundararajan V(undefined)undefined undefined undefined undefined-undefined

[9]

Halfon P(undefined)undefined undefined undefined undefined-undefined

← 1 →